APYX MEDICAL CORPORATION REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS
Initiated full U.S. commercial launch of AYON Body Contouring System™ (AYON) at end of Q3 2025, with demand for pre-orders exceeding expectations Submitted new 510(k) for AYON for device label [...]